Role of miR-17-92 miRNAs in skeletal development and bone homeostasis

miR-17-92 miRNA 在骨骼发育和骨稳态中的作用

• 批准号: 9241351
• 负责人: TATSUYA KOBAYASHI
• 金额: $ 36.76万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2021-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9241351
• 关键词: Alpha Cell; Animal Model; Antibodies; Biological Assay; Biological Process; Bone Diseases; Cell Differentiation process; Cell Proliferation; Cells; DNA Sequence Alteration; Data; Defect; Development; Digit structure; Disease; Family; Gene Expression; Gene Targeting; Genes; Genetic; Genetic Transcription; Homeostasis; Human; Individual; Intervention; Knowledge; Label; Limb Development; Macrocephaly; Maintenance; Mediating; Mesenchymal Stem Cells; MicroRNAs; Molecular; Molecular Target; Mus; Mutation; Osteoporosis; Pathologic; Pathway interactions; Pharmacology; Phenotype; Physiological; Play; Process; RNA; RNA immunoprecipitation sequencing; Regulation; Reporter; Reporting; Resolution; Role; Signal Pathway; Skeletal Development; Skeletal bone; Skeletal system; Stem cells; Syndrome; Techniques; Testing; Therapeutic; Tissues; Transgenic Mice; base; bone; bone mass; in vivo; limb bone; member; mouse model; novel therapeutic intervention; osteoblast differentiation; osteoprogenitor cell; overexpression; postnatal; public health relevance; skeletal; skeletal abnormality; skeletal disorder; skeletal dysplasia; skeletal tissue; stem; transcriptome sequencing; treatment strategy

 DESCRIPTION (provided by applicant): microRNAs (miRNAs) play critical regulatory roles in multiple types of skeletal cells. Despite the accumulating evidence for miRNAs' involvement in multiple processes of skeletal development and homeostasis, specific roles of individual miRNAs in vivo are largely unknown. miR-17-92 miRNAs are abundantly expressed in stem/progenitor cells and are implicated in their maintenance by promoting proliferation and suppressing differentiation. miR-17-92 cluster miRNAs are so far the only miRNAs whose genetic mutations have been demonstrated to cause human congenital skeletal diseases; duplications of the miR-17-92 gene cause macrocephaly and digit abnormalities, whereas its heterozygous deletions result in Feingold syndrome II that is characterized by macrocephaly and brachysyndactyly. In addition, we have also found that miR-17- 92 miRNAs negatively regulate osteoblast differentiation and bone mass in mice. However, the mechanisms by which miR-17-92 miRNAs regulate skeletal development and bone homeostasis are unknown. Because miR-17-92 miRNAs are predicted to target more than 2,000 genes, identifying critical molecular mechanisms is a challenge. On the other hand, it is presumed that physiologically important miRNA-RNA interactions are evolutionarily selected to control certain biological processes and pathways, as miR-17-92 miRNAs have been reported to regulate several signaling pathways in a cellular context dependent manner. Based on these findings, we hypothesize that miR-17-92 miRNAs regulate key signaling pathways in skeletal stem/progenitor cells to control their proliferation and differentiation, and thus regulate skeleta development and bone homeostasis. To test this hypothesis, we will first generate mouse models to define the role of miR-17-92 miRNAs in skeletal development and postnatal bone homeostasis at the tissue and cellular levels in vivo. We will then dissect molecular mechanisms that mediate miR-17-92 miRNAs' action at the levels of miRNA-RNA interaction, gene expression, and signaling pathways. This project will define the role and mechanisms of action of miR-17-92 miRNAs in skeletal stem/progenitor cells during skeletal development and bone homeostasis and will provide the basis for developing new therapeutic strategies for miR-17-92-related diseases and for common skeletal diseases such as osteoporosis.

 描述(申请人提供)：microRNAs(MiRNAs)在多种类型的骨骼细胞中起着关键的调节作用。尽管越来越多的证据表明miRNAs参与了骨骼发育和动态平衡的多个过程，但单个miRNAs在体内的具体作用在很大程度上是未知的。MiR-17-92 miRNAs在干/祖细胞中大量表达，并通过促进增殖和抑制分化参与其维持。到目前为止，miR-17-92簇miRNAs是唯一被证明其基因突变导致人类先天性骨骼疾病的miRNAs；miR-17-92基因的重复导致巨头畸形和手指畸形，而其杂合缺失导致以巨头畸形和短并指为特征的Feingold综合征II。此外，我们还发现miR-17-92 miRNAs负向调节小鼠成骨细胞分化和骨量。然而，miR-17-92 miRNAs调控骨骼发育和骨稳态的机制尚不清楚。由于miR-17-92 miRNAs被预测以2000多个基因为靶标，因此识别关键的分子机制是一个挑战。另一方面，人们推测，在进化过程中，重要的miRNA-RNA相互作用被选择来控制某些生物学过程和途径，因为miR-17-92miRNAs被报道以细胞上下文依赖的方式调节几个信号通路。基于这些发现，我们假设miR-17-92miRNAs调控骨骼干/祖细胞中的关键信号通路，以控制其增殖和分化，从而调节骨骼发育和骨稳态。为了验证这一假设，我们将首先建立小鼠模型，在体内组织和细胞水平上确定miR-17-92miRNAs在骨骼发育和出生后骨骼动态平衡中的作用。然后，我们将在miRNA-RNA相互作用、基因表达和信号通路的水平上剖析介导miR-17-92miRNAs作用的分子机制。本项目将确定miR-17-92 miRNAs在骨骼发育和骨内稳态过程中在骨骼干/祖细胞中的作用和作用机制，并将为开发miR-17-92相关疾病和常见骨骼疾病(如骨质疏松)的新治疗策略提供基础。